524 related articles for article (PubMed ID: 18714164)
1. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
3. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population.
Airoldi M; Gabriele AM; Garzaro M; Raimondo L; Condello C; Beatrice F; Pecorari G; Giordano C
Radiother Oncol; 2009 Jul; 92(1):105-10. PubMed ID: 19264368
[TBL] [Abstract][Full Text] [Related]
7. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Zheng J; Wang G; Yang GY; Wang D; Luo X; Chen C; Zhang Z; Li Q; Xu W; Li Z; Wang D
Jpn J Clin Oncol; 2010 May; 40(5):425-31. PubMed ID: 20085903
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma.
Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K
Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756
[TBL] [Abstract][Full Text] [Related]
10. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea.
Park KH; Kim JS; Park Y; Seo HY; Park YJ; Choi IK; Oh SC; Seo JH; Kim CY; Jung KY; Shin SW; Kim YH; Kim JS; Lee NJ
Cancer Chemother Pharmacol; 2010 Sep; 66(4):643-51. PubMed ID: 20033411
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ
Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
[TBL] [Abstract][Full Text] [Related]
20. [Concomitant chemo-radiotherapy for locoregionally advanced nasopharygeal carcinoma].
Tian Y; Chua DT; Sham JS
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):429-31. PubMed ID: 16188131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
